Financière de Tubize SA (EBR:TUB)
Belgium · Delayed Price · Currency is EUR 236.20
+5.40 (2.34%)
Jun 11, 2026, 5:35 PM CET
Financière de Tubize Market Cap
Financière de Tubize has a market cap or net worth of €10.51 billion as of June 11, 2026. Its market cap has increased by 86.28% in one year.
Market Cap
10.51B
Enterprise Value
10.51B
Revenue
n/a
Ranking
n/a
PE Ratio
112.78
Stock Price
€236.20
Market Cap Chart
Since April 16, 2001, Financière de Tubize's market cap has increased from 1.37B to 10.51B, an increase of 666.50%. That is a compound annual growth rate of 8.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 10, 2026 | 10.27B | 10.43% |
| Dec 31, 2025 | 9.30B | 46.98% |
| Dec 31, 2024 | 6.33B | 98.33% |
| Dec 29, 2023 | 3.19B | 1.27% |
| Dec 30, 2022 | 3.15B | -21.59% |
| Dec 31, 2021 | 4.02B | 9.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 51.59B |
| argenx SE | 47.45B |
| Onward Medical | 184.60M |
| Hyloris Pharmaceuticals | 137.76M |
| European Medical Solutions | 21.16M |
| Celyad Oncology | 12.71M |
| BioSenic | 1.31M |
| Oxurion NV | 266.07K |